Research & KnowledgeEvent: September 2, 2026
Psychedelic Alpha announced the ASCENT-IBO funding opportunity for the ARPA-H Ibogaine Trial.
Published
Signal category
Research & Knowledge
Quote
“ASCENT-IBO: ARPA-H’s Ibogaine Trial Funding Opportunity”
— Psychedelic Alpha team
Company
Psychedelic Alpha
The leading independent, data-driven voice in psychedelics.
- Industry
- Business Consulting and Services
- Location
- London, GB
- Company size
- 5 employees
The definitive resource for analysis of the emergent psychedelic medicine sector. Cut through the noise with exclusive news, interviews, data and opportunities.
Founded 2020